InfoBionic Appoints Gene Cattarina to Board of Directors

InfoBionic has announced the appointment of Gene Cattarina to its board of directors. Based in Boston, MA, InfoBionic is a digital health company focused on creating superior patient monitoring solutions for chronic disease management.

In his new position, Cattarina will help InfoBionic continue to scale up commercialization of its MoMe® Kardia Software as a Service (SaaS) remote cardiac monitoring platform.

Cattarina is CEO of SafeOp Surgical, Inc., a medical device company that has developed the FDA-approved EPAD system for simplified neurological monitoring. Prior to SafeOp, Cattarina was president and CEO of Capsule Technologie, Inc., a global provider of medical device integration solutions, which was acquired by Qualcomm, Inc. (NASDAQ: QCOM) in 2015.

“For decades, Gene has been on the forefront of healthcare information technology and medical device innovation, and his track record of success speaks for itself,” said Stuart Long, CEO of InfoBionic. “His experience, perspective, and counsel will no doubt be of great value to InfoBionic as we continue to scale our disruptive platform.”

“InfoBionic is challenging the status quo of traditional, complex processes for remote cardiac monitoring, offering innovative full disclosure technology in a game-changing business model,” said Cattarina. “I look forward to working with InfoBionic’s exceptional team, and to contributing to the future direction and growth of their transformative platform.”